Clinical Data

Eli Lilly

Pharma

Lilly touts Zepbound-Taltz combo in patients with obesity, PsA

Taking Zepbound with Taltz could help patients with both obesity and psoriatic arthritis more than Taltz on its own, according to new Eli Lilly data.

Fraiser Kansteiner Jan 8, 2026 2:00pm

An envelope with rejected mark Vector illustration

Fierce Biotech

FDA shares CRL for Sanofi MS drug mere weeks after rebuff

Jan 6, 2026 4:30am

An arrow incrementally going up stairs before pointing straight up Blue background

Regeneron, AZ regulatory plans bolstered by phase 3 wins

Nov 7, 2025 2:00pm

Argenx

Argenx lays out details on Vyvgart's seronegative gMG win

Oct 29, 2025 2:34pm

Merck

Welireg's RCC wins could pad Merck's post-Keytruda sales

Oct 28, 2025 3:00pm

Human kidney anatomy

Roche pads case for Gazyva in immune-mediated kidney conditions

Oct 28, 2025 9:55am